Abstract:Abstract Background The prevalence of Crohn's disease in the elderly is increasing today. The purpose of this study was to analyze the clinical characteristics of elderly-onset patients with Crohn's disease and compare with non-elderly-onset adult patients. Methods All Crohn's disease patients with onset aged 60 years and older at our Inflammatory Bowel Disease Center in recently ten years were retrospectively included. The elderly were compared with adult patients aged 18-59 at the time of onset, who were matched according to diagnosis time and gender by a 1:3 ratio of propensity score matching. After matching, the clinical data were recorded and analyzed to compared between the two groups of patients. Results A total of 68 patients were included, including 17 patients in the elderly-onset group and 51 patients in the non-elderly-onset adult group. The mean age of diagnosis in the two groups was 30.3±8.7 years and 63.9±4.24 years, and the mean course of disease was 30.3 months and 63.9 months, respectively. According to the Montreal classification, most elderly patients presented with L3 (70.6%) and B1 (58.8%), no cases involving the upper digestive tract or multiple lesion sites, showed mild disease activity (76.5%). The elderly group had fewer intestinal complications and parenteral manifestations. The medication types of elderly are 5-aminosalicylates (52.9%), traditional immunosuppressive agents (45.6%) and enteral nutrition preparations (29.4%) being the more frequent types of medications used, and glucocorticoids and biologics being used less frequently. Exposure to two or more IBD medications was 31.4% and 52.9% in the non-elderly onset adult group versus the elderly onset group, respectively (p=0.110). During follow-up, symptoms such as diarrhea (11.8 vs 5.9%), abdominal pain (35.3% vs 17.6%) and weight loss (11.8% vs 3.9%) were more common in the elderly-onset group. Elderly patients had more hospitalizations on average (0.22 vs. 1.12). 40.7% of elderly patients underwent CD-related surgery during the duration of their disease, with 50.0% of patients undergoing reoperation. Conclusion Compared with non-elderly-onset adult patients, elderly-onset patients with Crohn's disease are more common in women, and the lesion mainly in the ileum and ilecolon; the disease behavior is mainly B1; nearly half of the patients have intestinal complications The elderly have atypical clinical manifestations, basically haven’t family history of IBD, take longer to diagnose, have more underlying diseases, more hospitalizations on average, and are more likely to have complications. They are more likely to receive conservative treatment, but with more frequent medication adjustments and a higher likelihood of undergoing CD-related surgery.

Crohn's Disease of the Elderly: Unique Biology and Therapeutic Efficacy and Safety

The elderly IBD patient in the modern era: changing paradigms in risk stratification and therapeutic management

P1025 Analysis of the Clinical Characteristics of Elderly-onset Crohn's Disease

Medical Management of Inflammatory Bowel Disease in the Elderly

A Focus on Disease Characteristics and Biological Therapy Patterns

Microbial-Immune Crosstalk in Elderly-Onset Inflammatory Bowel Disease: Unchartered Territory

[Treatment of Inflammatory Bowel Disease in Elderly Patients - What Are Different and What Should We Know?]

Clinical characteristics of elderly-onset inflammatory bowel disease and its treatment options

Characterization of Inflammatory Bowel Disease in the Elderly According to Age of Onset

Efficacy and Safety of Biological Therapies and JAK Inhibitors in Older Patients with Inflammatory Bowel Disease

IBD in the Elderly: Management Challenges and Therapeutic Considerations

Management of inflammatory bowel disease in the elderly: A review

Management Considerations for the Older Adult With Inflammatory Bowel Disease

Frailty in inflammatory bowel diseases: an emerging concept

The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations-IBD in Seniors

Management of inflammatory bowel diseases in older adults

Considerations on Multimorbidity and Frailty in Inflammatory Bowel Diseases

Systematic Review and Meta-analysis: Phenotype and Clinical Outcomes of Older-Onset Inflammatory Bowel Disease

Ulcerative Colitis in Adulthood and in Older Patients: Same Disease, Same Outcome, Same Risks?

P287 Clinical aspects of late-age Onset Inflammatory Bowel Disease

Drug Management in the Elderly IBD Patient